Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-03-02

FDA Approved: MOEXIPRIL HYDROCHLORIDE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

FDA approved Glenmark's Moexipril hydrochloride under a supplemental ANDA, expanding the availability of a generic Moexipril product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Moexipril hydrochloride (Moexipril hydrochloride)

Snippet

SUPPL AP for MOEXIPRIL HYDROCHLORIDE (MOEXIPRIL HYDROCHLORIDE)